| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Common Stock | Options Exercise | $78,794 | +1,004 | +6.5% | $78.48 | 16,486 | 10 May 2023 | Direct | |
| transaction | RGA | Common Stock | Tax liability | $48,354 | -328 | -2% | $147.42 | 16,158 | 10 May 2023 | Direct | F1 |
| transaction | RGA | Common Stock | Sale | $100,325 | -676 | -4.2% | $148.41 | 15,482 | 10 May 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Stock Appreciation Right (right to purchase) 2014 | Options Exercise | $0 | -2,147 | -100% | $0.000000* | 0 | 10 May 2023 | Common Stock | 2,147 | $78.48 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents (i) 1,143 shares sold to pay the exercise price the purchase of common stock, and (ii) 328 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 676 shares. |
| F2 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |